Ownership

Hale David F - Director at Oncternal Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Company
Role: Director
Stock Symbol: ONCT on Nasdaq
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

Hale David F - trading volume in the past year for Oncternal Therapeutics, Inc.

	Shares	%	Avg Price	Total $
Buys	+980	100%	$9.04	+$8.86K
Sells
Net	+980	100%		+$8.86K

Holdings reported by Hale David F for Oncternal Therapeutics, Inc.

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	29.7K	$268K	$9.04	Feb 23, 2024	By Hale BioPharma Ventures, LLC
Common Stock	917	$8.29K	$9.04	Feb 23, 2024	By Hale Trading Company
Common Stock	714	$6.45K	$9.04	Feb 23, 2024	Direct
Stock Options	3.3K			Jun 20, 2024	Direct	Common Stock

Transactions reported by Hale David F for Oncternal Therapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.